Jiangxi
300497.SZJiangxi Fushine Pharmaceutical Co., Ltd. Price (300497.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
542,702,836
(0.7526)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Jiangxi Fushine Pharmaceutical Co., Ltd.Currency: CNY
| YEAR | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
291,367,461.00
+0% |
360,320,580.00
+24% |
442,842,086.00
+23% |
510,727,122.00
+15% |
579,743,065.00
+14% |
763,686,934.00
+32% |
958,150,476.00
+25% |
1,163,433,590.00
+21% |
1,354,046,811.00
+16% |
1,492,952,990.00
+10% |
1,429,542,874.00
-4% |
1,647,263,426.00
+15% |
1,609,669,988.00
-2% |
||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 209,108,733.00 | 267,297,498.00 | 328,057,388.00 | 371,269,314.00 | 374,083,502.00 | 437,211,264.00 | 592,161,789.00 | 730,017,761.00 | 770,342,005.00 | 889,238,424.00 | 993,554,921.00 | 1,350,160,738.00 | 1,471,349,273.00 | ||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
82,258,728.00
+0% |
93,023,082.00
+13% |
114,784,698.00
+23% |
139,457,808.00
+21% |
205,659,563.00
+47% |
326,475,670.00
+59% |
365,988,687.00
+12% |
433,415,829.00
+18% |
583,704,806.00
+35% |
603,714,566.00
+3% |
435,987,953.00
-28% |
297,102,688.00
-32% |
138,320,715.00
-53% |
||||||
| Gross Profit Ratio | (0.28%) | (0.26%) | (0.26%) | (0.27%) | (0.35%) | (0.43%) | (0.38%) | (0.37%) | (0.43%) | (0.40%) | (0.31%) | (0.18%) | (0.09%) | ||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 13,110,534.00 | 13,992,116.00 | 17,865,861.00 | 18,331,460.00 | 30,901,215.00 | 43,508,793.00 | 52,877,362.00 | 59,456,016.00 | 76,526,925.00 | 78,511,845.00 | 77,450,427.00 | 97,453,168.00 | ||||||
| General and Administrative | 29,647,302.00 | 6,454,406.00 | 8,089,894.00 | 10,216,526.00 | 15,850,557.00 | 23,271,759.00 | 24,272,147.00 | 25,054,880.00 | 29,629,478.00 | 31,330,938.00 | 36,679,595.00 | 42,752,601.00 | 46,865,926.00 | ||||||
| Selling, General & Admin... | 39,423,252.00 | 16,375,427.00 | 20,298,758.00 | 26,064,661.00 | 31,343,759.00 | 41,592,807.00 | 42,554,036.00 | 50,354,106.00 | 57,114,615.00 | 52,171,975.00 | 71,179,153.00 | 76,964,839.00 | 194,460,409.00 | ||||||
| Selling & Marketing Exp... | 9,775,949.00 | 9,921,021.00 | 12,208,864.00 | 15,848,135.00 | 15,493,202.00 | 18,321,048.00 | 18,281,888.00 | 25,299,226.00 | 27,485,136.00 | 20,841,036.00 | 34,499,558.00 | 34,212,237.00 | 29,671,056.00 | ||||||
| Depreciation and Amortiz... | 4,782,782.00 | 10,246,683.00 | 17,477,988.00 | 23,235,036.00 | 28,502,475.00 | 34,422,917.00 | 45,727,199.00 | 54,012,693.00 | 67,791,522.00 | 74,514,063.00 | 97,637,669.00 | 121,741,825.00 | 159,458,710.00 | ||||||
| Other Expenses | 5,986,124.00 | 6,213,533.00 | 5,677,350.00 | 3,098,368.00 | 3,820,283.00 | 19,488,794.00 | 3,467,760.00 | -4,084,691.88 | -10,905,798.50 | -8,180,869.12 | -85,984,526.66 | -87,533,611.29 | 75,796,248.00 | ||||||
| Total Operating Expenses | 40,406,524.00 | 43,532,442.00 | 56,368,010.00 | 69,701,500.00 | 84,198,231.00 | 141,592,350.00 | 154,443,224.00 | 177,929,777.00 | 173,894,646.00 | 170,297,378.00 | 229,769,456.00 | 259,410,612.00 | 367,709,825.00 | ||||||
| Cost and Exponses | 249,515,258.00 | 310,829,940.00 | 384,425,399.00 | 440,970,814.00 | 458,281,733.00 | 578,803,615.00 | 746,605,013.00 | 907,947,539.00 | 944,236,651.00 | 1,059,535,802.00 | 1,223,324,377.00 | 1,609,571,350.00 | 1,839,059,098.00 | ||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
36,805,433.00
+0% |
40,900,321.00
+11% |
47,483,641.00
+16% |
60,832,890.00
+28% |
109,902,723.00
+81% |
188,542,149.00
+72% |
197,585,222.00
+5% |
231,161,285.00
+17% |
369,263,978.00
+60% |
386,992,243.00
+5% |
57,003,840.00
-85% |
-133,954,884.36
-335% |
-229,389,111.00
+71% |
||||||
| Operating Income Ratio | (0.13%) | (0.11%) | (0.11%) | (0.12%) | (0.19%) | (0.25%) | (0.21%) | (0.20%) | (0.27%) | (0.26%) | (0.04%) | (-0.08%) | (-0.14%) | ||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | -0.68 | 722,978.00 | 666,906.00 | 1,038,329.00 | 1,330,148.00 | 2,477,243.00 | 5,991,004.00 | 7,087,007.00 | 9,653,037.00 | 14,678,601.00 | 16,397,434.00 | 23,294,395.00 | 8,249,384.00 | ||||||
| Interest Expenses | 6,476,500.00 | 7,135,665.00 | 8,540,753.00 | 9,518,281.00 | 11,240,152.00 | 8,258,002.00 | 15,315,120.00 | 24,050,924.00 | 33,105,817.00 | 23,737,332.00 | 24,919,684.00 | 41,098,468.00 | 42,031,308.00 | ||||||
| Total Other Income/Exp... | 5,465,379.00 | 5,843,106.00 | 5,442,197.00 | 2,769,495.00 | 1,682,109.00 | 15,462,272.00 | 3,467,761.00 | -4,084,686.00 | -10,905,791.00 | -8,180,863.00 | -1,935,594.00 | -8,752,471.00 | -3,781,768.99 | ||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 41,852,202.00 | 74,659,755.00 | 78,944,581.00 | 96,355,702.00 | 144,706,197.00 | 246,635,074.00 | 261,565,352.00 | 303,961,246.00 | 457,990,857.00 | 476,481,334.00 | 178,556,342.00 | 22,228,725.00 | -31,680,860.60 | ||||||
| EBITDA ratio | (0.14%) | (0.18%) | (0.18%) | (0.19%) | (0.27%) | (0.33%) | (0.27%) | (0.27%) | (0.35%) | (0.32%) | (0.13%) | (0.07%) | (-0.02%) | ||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 42,270,812.00 | 46,743,427.00 | 52,925,838.00 | 63,602,384.00 | 111,584,832.00 | 203,629,395.00 | 201,052,983.00 | 227,076,593.00 | 358,358,180.00 | 378,811,374.00 | 55,068,237.00 | -142,707,362.06 | -233,170,879.99 | ||||||
| Income Before Tax Ratio | (0.15%) | (0.13%) | (0.12%) | (0.12%) | (0.19%) | (0.27%) | (0.21%) | (0.20%) | (0.26%) | (0.25%) | (0.04%) | (-0.09%) | (-0.14%) | ||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 6,423,543.00 | 6,663,994.00 | 7,853,151.00 | 10,161,142.00 | 17,983,064.00 | 31,109,164.00 | 26,576,251.00 | 34,714,739.00 | 51,478,135.00 | 56,632,706.00 | 15,530,178.00 | 21,467,179.00 | -9,914,787.00 | ||||||
| Net Income | |||||||||||||||||||
| Net Income | 35,847,268.00
+0% |
40,079,432.00
+12% |
45,072,687.00
+12% |
53,441,241.00
+19% |
93,601,767.00
+75% |
173,909,446.00
+86% |
177,550,392.00
+2% |
194,724,797.00
+10% |
305,835,258.00
+57% |
319,300,200.00
+4% |
48,830,662.00
-85% |
-141,471,326.16
-390% |
-200,800,049.00
+42% |
||||||
| Net Income Ratio | (0.12%) | (0.11%) | (0.10%) | (0.10%) | (0.16%) | (0.23%) | (0.19%) | (0.17%) | (0.23%) | (0.21%) | (0.03%) | (-0.09%) | (-0.12%) | ||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.39 | 0.14 | 0.14 | 0.17 | 0.30 | 0.42 | 0.42 | 0.46 | 0.71 | 0.70 | 0.09 | -0.26 | -0.37 | ||||||
| Diluted EPS | 0.39 | 0.14 | 0.14 | 0.17 | 0.30 | 0.41 | 0.42 | 0.45 | 0.67 | 0.69 | 0.09 | -0.26 | -0.37 | ||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 0.00 | 295,971,194.00 | 312,793,588.00 | 310,930,862.00 | 309,854,127.00 | 414,790,233.00 | 420,860,190.00 | 426,794,076.00 | 427,966,838.00 | 456,143,143.00 | 544,205,990.00 | 538,648,934.00 | 542,702,836.00 | ||||||
| Diluted Share Outstanding | 0.00 | 295,971,194.00 | 312,793,588.00 | 310,930,862.00 | 309,854,127.00 | 422,665,997.00 | 420,860,190.00 | 432,721,771.00 | 456,470,534.00 | 462,753,913.00 | 544,205,990.00 | 538,648,934.00 | 542,702,836.00 | ||||||